Literature DB >> 24820020

VEGF regulates region-specific localization of perivascular bone marrow-derived cells in glioblastoma.

Kelly Burrell1, Sanjay Singh1, Shahrzad Jalali1, Richard P Hill2, Gelareh Zadeh3.   

Abstract

Glioblastoma multiforme (GBM) is characterized by a pathogenic vasculature that drives aggressive local invasion. Recent work suggests that GBM cells recruit bone marrow-derived progenitor cells (BMDC) to facilitate recurrence after radiotherapy, but how this may be achieved is unclear. In this study, we established the spatiotemporal and regional contributions of perivascular BMDCs (pBMDC) to GBM development. We found an increased recruitment of BMDCs to GBM in response to tumor growth and following radiotherapy. However, in this study, BMDCs did not differentiate into endothelial cells directly but rather provided a perivascular support role. The pBMDCs were shown to associate with tumor vasculature in a highly region-dependent manner, with central vasculature requiring minimal pBMDC support. Region-dependent association of pBMDC was regulated by VEGF. In the absence of VEGF, following radiotherapy or antiangiogenic therapy, we documented an increase in Ang2 that regulated recruitment of pBMDCs to maintain the vulnerable central vasculature. Together, our results strongly suggested that targeting pBMDC influx along with radiation or antiangiogenic therapy would be critical to prevent vascular recurrence of GBM. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820020     DOI: 10.1158/0008-5472.CAN-13-3119

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  The changing paradigm of tumour response to irradiation.

Authors:  Richard P Hill
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

2.  Immune effects of bevacizumab: killing two birds with one stone.

Authors:  Yasir Y Elamin; Shereen Rafee; Sinead Toomey; Bryan T Hennessy
Journal:  Cancer Microenviron       Date:  2014-10-18

3.  Bevacizumab treatment for newly diagnosed glioblastoma: Systematic review and meta-analysis of clinical trials.

Authors:  Peng Fu; Yun-Song He; Qin Huang; Tao Ding; Yong-Cun Cen; Hong-Yang Zhao; Xiang Wei
Journal:  Mol Clin Oncol       Date:  2016-03-10

Review 4.  Extracellular Vesicles in Brain Tumor Progression.

Authors:  Esterina D'Asti; Shilpa Chennakrishnaiah; Tae Hoon Lee; Janusz Rak
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

Review 5.  The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.

Authors:  Holly E Barker; James T E Paget; Aadil A Khan; Kevin J Harrington
Journal:  Nat Rev Cancer       Date:  2015-07       Impact factor: 60.716

6.  A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center.

Authors:  Evan K Noch; Sameer F Sait; Shama Farooq; Tanya M Trippett; Alexandra M Miller
Journal:  Neurooncol Pract       Date:  2021-02-03

7.  Ruta graveolens L. induces death of glioblastoma cells and neural progenitors, but not of neurons, via ERK 1/2 and AKT activation.

Authors:  Maria Teresa Gentile; Claudia Ciniglia; Mafalda G Reccia; Floriana Volpicelli; Monica Gatti; Stefano Thellung; Tullio Florio; Mariarosa A B Melone; Luca Colucci-D'Amato
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

8.  Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1.

Authors:  Ding Ma; Daqian Zhan; Yi Fu; Shuang Wei; Bachchu Lal; Jie Wang; Yunqing Li; Hernando Lopez-Bertoni; Fatih Yalcin; Omar Dzaye; Charles G Eberhart; John Laterra; Mary Ann Wilson; Mingyao Ying; Shuli Xia
Journal:  Cancer Lett       Date:  2021-06-05       Impact factor: 9.756

9.  Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.

Authors:  Alexander Scholz; Patrick N Harter; Sebastian Cremer; Burak H Yalcin; Stefanie Gurnik; Maiko Yamaji; Mariangela Di Tacchio; Kathleen Sommer; Peter Baumgarten; Oliver Bähr; Joachim P Steinbach; Jörg Trojan; Martin Glas; Ulrich Herrlinger; Dietmar Krex; Matthias Meinhardt; Astrid Weyerbrock; Marco Timmer; Roland Goldbrunner; Martina Deckert; Christian Braun; Jens Schittenhelm; Jochen T Frueh; Evelyn Ullrich; Michel Mittelbronn; Karl H Plate; Yvonne Reiss
Journal:  EMBO Mol Med       Date:  2016-01-01       Impact factor: 12.137

10.  Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion.

Authors:  Ching-Fang Yu; Fang-Hsin Chen; Meng-Hsuan Lu; Ji-Hong Hong; Chi-Shiun Chiang
Journal:  Br J Cancer       Date:  2017-10-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.